18 February 2025
18 February 2025
Neonav is specifically designed to aid in venous access device placement in paediatric patients.
The agency’s decision summary of the test included an evaluation of its analytical performance.
The partnership aims to deliver insights into cancer, cardiovascular, and other health condition risks.
Deployed in over 100 US healthcare systems, Abridge has landed one of the largest genAI fundings in healthcare to date.
The tools ideate on Boston Scientific’s Farapulse PFA system, which contributed towards a 172% uptick in the company’s Q4 2024 revenues.
The product is packaged in pouches, with one applicator per pouch and 60 applicators per inner carton.
According to EDX, the test studies the most comprehensive range of clinically validated prostate-related biomarkers currently known.
The temporary suspension of the device's US rollout began last month following reports of four stroke events.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
